-
Osteoporosis risk-assessment related lifestyle and metabolic factors: A population-based study
Lili You, Feng Li, Wanting Feng, Xiaoyi Wang, Meng Ren, Muchao Wu, Jin Zhang, Chuan Wang, Juying Tang, Xiaoyun Zhang, Li Yan, and Mingtong Xu
Research Article: Clinical Investigation
-
Osteoporosis risk-assessment related lifestyle and metabolic factors: A population-based study
Lili You, Feng Li, Wanting Feng, Xiaoyi Wang, Meng Ren, Muchao Wu, Jin Zhang, Chuan Wang, Juying Tang, Xiaoyun Zhang, Li Yan, and Mingtong Xu
Research Article: Clinical Investigation
-
Osteoporosis risk-assessment related lifestyle and metabolic factors: A population-based study
Lili You, Feng Li, Wanting Feng, Xiaoyi Wang, Meng Ren, Muchao Wu, Jin Zhang, Chuan Wang, Juying Tang, Xiaoyun Zhang, Li Yan, and Mingtong Xu
Research Article: Clinical Investigation
-
Osteoporosis risk-assessment related lifestyle and metabolic factors: A population-based study
Lili You, Feng Li, Wanting Feng, Xiaoyi Wang, Meng Ren, Muchao Wu, Jin Zhang, Chuan Wang, Juying Tang, Xiaoyun Zhang, Li Yan, and Mingtong Xu
Research Article: Clinical Investigation
-
Osteoporosis risk-assessment related lifestyle and metabolic factors: A population-based study
Lili You, Feng Li, Wanting Feng, Xiaoyi Wang, Meng Ren, Muchao Wu, Jin Zhang, Chuan Wang, Juying Tang, Xiaoyun Zhang, Li Yan, and Mingtong Xu
Research Article: Clinical Investigation
-
Osteoporosis risk-assessment related lifestyle and metabolic factors: A population-based study
Lili You, Feng Li, Wanting Feng, Xiaoyi Wang, Meng Ren, Muchao Wu, Jin Zhang, Chuan Wang, Juying Tang, Xiaoyun Zhang, Li Yan, and Mingtong Xu
Research Article: Clinical Investigation
-
Rechallenge with imatinib in advanced gastrointestinal stromal tumors: clinical implications of the RIGHT trial
Changhoon Yoo & Yoon-Koo Kang
Review: Clinical Trail Outcomes: Clinical Investigation
-
Rechallenge with imatinib in advanced gastrointestinal stromal tumors: clinical implications of the RIGHT trial
Changhoon Yoo & Yoon-Koo Kang
Review: Clinical Trail Outcomes: Clinical Investigation
-
Rechallenge with imatinib in advanced gastrointestinal stromal tumors: clinical implications of the RIGHT trial
Changhoon Yoo & Yoon-Koo Kang
Review: Clinical Trail Outcomes: Clinical Investigation
-
Rechallenge with imatinib in advanced gastrointestinal stromal tumors: clinical implications of the RIGHT trial
Changhoon Yoo & Yoon-Koo Kang
Review: Clinical Trail Outcomes: Clinical Investigation
-
Rechallenge with imatinib in advanced gastrointestinal stromal tumors: clinical implications of the RIGHT trial
Changhoon Yoo & Yoon-Koo Kang
Review: Clinical Trail Outcomes: Clinical Investigation
-
Rechallenge with imatinib in advanced gastrointestinal stromal tumors: clinical implications of the RIGHT trial
Changhoon Yoo & Yoon-Koo Kang
Review: Clinical Trail Outcomes: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 2
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 2
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 2
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 2
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 2
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 2
Acknowledgements: Clinical Investigation
-
Monoclonal antibody therapy for classical Hodgkin lymphoma
Ewa Paszkiewicz-Kozik ,an Walewski
Review: Clinical Trail Outcomes: Clinical Investigation
-
Monoclonal antibody therapy for classical Hodgkin lymphoma
Ewa Paszkiewicz-Kozik ,an Walewski
Review: Clinical Trail Outcomes: Clinical Investigation
-
Monoclonal antibody therapy for classical Hodgkin lymphoma
Ewa Paszkiewicz-Kozik ,an Walewski
Review: Clinical Trail Outcomes: Clinical Investigation
-
Monoclonal antibody therapy for classical Hodgkin lymphoma
Ewa Paszkiewicz-Kozik ,an Walewski
Review: Clinical Trail Outcomes: Clinical Investigation
-
Monoclonal antibody therapy for classical Hodgkin lymphoma
Ewa Paszkiewicz-Kozik ,an Walewski
Review: Clinical Trail Outcomes: Clinical Investigation
-
Monoclonal antibody therapy for classical Hodgkin lymphoma
Ewa Paszkiewicz-Kozik ,an Walewski
Review: Clinical Trail Outcomes: Clinical Investigation
-
Developing a National Network for Clinical Research: The NIHR Medicines for Children Research Network (MCRN)
Gemma L Saint, Vanessa Poustie, Rosalind L Smyth
Research Update: Clinical Investigation
-
Developing a National Network for Clinical Research: The NIHR Medicines for Children Research Network (MCRN)
Gemma L Saint, Vanessa Poustie, Rosalind L Smyth
Research Update: Clinical Investigation
-
Developing a National Network for Clinical Research: The NIHR Medicines for Children Research Network (MCRN)
Gemma L Saint, Vanessa Poustie, Rosalind L Smyth
Research Update: Clinical Investigation
-
Developing a National Network for Clinical Research: The NIHR Medicines for Children Research Network (MCRN)
Gemma L Saint, Vanessa Poustie, Rosalind L Smyth
Research Update: Clinical Investigation
-
Developing a National Network for Clinical Research: The NIHR Medicines for Children Research Network (MCRN)
Gemma L Saint, Vanessa Poustie, Rosalind L Smyth
Research Update: Clinical Investigation
-
Developing a National Network for Clinical Research: The NIHR Medicines for Children Research Network (MCRN)
Gemma L Saint, Vanessa Poustie, Rosalind L Smyth
Research Update: Clinical Investigation
-
Personalized medicine in rheumatoid arthritis: rationale & clinical evidence
BC Visser, IH Brinkman, MAFJ van de Laar
Review: Clinical Trail Outcomes: Clinical Investigation
-
Personalized medicine in rheumatoid arthritis: rationale & clinical evidence
BC Visser, IH Brinkman, MAFJ van de Laar
Review: Clinical Trail Outcomes: Clinical Investigation
-
Personalized medicine in rheumatoid arthritis: rationale & clinical evidence
BC Visser, IH Brinkman, MAFJ van de Laar
Review: Clinical Trail Outcomes: Clinical Investigation
-
Personalized medicine in rheumatoid arthritis: rationale & clinical evidence
BC Visser, IH Brinkman, MAFJ van de Laar
Review: Clinical Trail Outcomes: Clinical Investigation
-
Personalized medicine in rheumatoid arthritis: rationale & clinical evidence
BC Visser, IH Brinkman, MAFJ van de Laar
Review: Clinical Trail Outcomes: Clinical Investigation
-
Personalized medicine in rheumatoid arthritis: rationale & clinical evidence
BC Visser, IH Brinkman, MAFJ van de Laar
Review: Clinical Trail Outcomes: Clinical Investigation
-
Design of clinical trials for biomarker research in oncology
Sumithra J Mandrekar, Daniel J Sargent
Clinical Trail Outcomes: Clinical Investigation
-
Design of clinical trials for biomarker research in oncology
Sumithra J Mandrekar, Daniel J Sargent
Clinical Trail Outcomes: Clinical Investigation
-
Design of clinical trials for biomarker research in oncology
Sumithra J Mandrekar, Daniel J Sargent
Clinical Trail Outcomes: Clinical Investigation
-
Design of clinical trials for biomarker research in oncology
Sumithra J Mandrekar, Daniel J Sargent
Clinical Trail Outcomes: Clinical Investigation
-
Design of clinical trials for biomarker research in oncology
Sumithra J Mandrekar, Daniel J Sargent
Clinical Trail Outcomes: Clinical Investigation
-
Design of clinical trials for biomarker research in oncology
Sumithra J Mandrekar, Daniel J Sargent
Clinical Trail Outcomes: Clinical Investigation
-
New considerations in the design of clinical trials for spondyloarthritis
Robert Landewe ,Desiree van der Heijde
Review Article: Clinical Investigation
-
New considerations in the design of clinical trials for spondyloarthritis
Robert Landewe ,Desiree van der Heijde
Review Article: Clinical Investigation
-
New considerations in the design of clinical trials for spondyloarthritis
Robert Landewe ,Desiree van der Heijde
Review Article: Clinical Investigation
-
New considerations in the design of clinical trials for spondyloarthritis
Robert Landewe ,Desiree van der Heijde
Review Article: Clinical Investigation
-
New considerations in the design of clinical trials for spondyloarthritis
Robert Landewe ,Desiree van der Heijde
Review Article: Clinical Investigation
-
New considerations in the design of clinical trials for spondyloarthritis
Robert Landewe ,Desiree van der Heijde
Review Article: Clinical Investigation